If you have been reading about AOD9604 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-05-09. Numbers and descriptions here follow the published literature rather than marketing material.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Status varies by country; prohibited in sport. |
| Common storage temperature | 2–8 °C for lyophilized powder | Protect from light and moisture; follow supplier instructions. |
| Typical analytical method | LC-MS/MS | Used for identification and quantification in biological samples. |
| Purity assessment | HPLC and mass spectrometry | Reverse-phase HPLC is common for peptide purity. |
| Common synonyms | AOD9604; hGH 176-191 fragment | Naming conventions differ across studies. |
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
In butterfly wing scales, chitin is organized into stacks of gyroids constructed of chitin photonic crystals that produce various iridescent colors serving phenotypic signaling and communication for mating and foraging. The elaborate chitin gyroid construction in butterfly wings creates a model of optical devices having potential for innovations in biomimicry. Scarab beetles in the genus Cyphochilus also utilize chitin to form extremely thin scales (five to fifteen micrometres thick) that diffusely reflect white light. These scales are networks of randomly ordered filaments of chitin with diameters on the scale of hundreds of nanometres, which serve to scatter light. The multiple scattering of light is thought to play a role in the unusual whiteness of the scales. In addition, some social wasps, such as Protopolybia chartergoides, orally secrete material containing predominantly chitin to reinforce the outer nest envelopes, composed of paper. Chitosan is produced commercially by deacetylation of chitin by treatment with sodium hydroxide. Chitosan has a wide range of biomedical applications including wound healing, drug delivery and tissue engineering. Due to its specific intermolecular hydrogen bonding network, dissolving chitin in water is very difficult. Chitosan (with a degree of deacetylation of more than ~28%), on the other hand, can be dissolved in dilute acidic aqueous solutions below a pH of 6.0 such as acetic, formic and lactic acids. Chitosan with a degree of deacetylation greater than ~49% is soluble in water.
17 November – Anton Hull, a drink-driver who filmed himself at the wheel saying he was "smashed" then went on to bill 29-year-old Sarah Baker in a crash in Somerset, is sentenced to six years imprisonment and given a nine-year driving ban. 18 November – Businesses in London have urged the UK government to relax Sunday trading hours because of the cost of living crisis, estimating longer trading hours would generate an extra £300m a year. A study of Bradford's Pakistani community finds that cousin marriage has dropped sharply over the past decade, with 60% of parents born to cousins ten years ago compared to 46% now. Ice hockey team Nottingham Panthers play their first game since the death of Adam Johnson. The Adam Johnson Memorial Game is played against Manchester Storm. 19 November – An earthquake measuring 2.7 magnitude strikes parts of Cornwall at 12.50am. 20 November – Four men are convicted of the August 2022 murder of Ashley Dale in Liverpool following a disagreement involving her boyfriend. 21 November – North Hertfordshire Museum announces it will reclassify the Roman Emperor Elagabalus as a trans woman in its display about the historical figure because classical texts claim the emperor once said "call me not Lord, for I am a Lady". 22 November – James Witham, Joseph Peers, Niall Barry, and Sean Zeisz are each sentenced to life imprisonment with minimum terms of over 40 years for the murder of Ashley Dale. 23 November – A man is shot dead by armed police in Dagenham after telling Met officers he wanted to kill himself and had loaded guns.
==== Glycopeptide-type CSP ==== Armstrong introduced macrocyclic glycopeptides (also known as glycopeptide antibiotics) as a new class of chiral selector for liquid chromatography in 1994. At present, vancomycin, teicoplanin and ristocetin are available under the brand names Chirobiotic V, Chirobiotic T and Chirobiotic R respectively. These cyclic glycopeptides have multiple chiral centers and a cup-like inclusion area to which a floating sugar lid is attached. Similar to protein chiral selectors, the amphoteric cyclic glycopeptides consist of peptide and carbohydrate binding sites leading to possibilities for different modes of interaction beside the formation of inclusion complexation. In this chiral selector the cavities are shallower than that of CDs and hence the interactions are weaker, allows more rapid solute exchange between phases, higher column efficiency. operates in normal phase, reversed-phase and polar organic phase. The complex structural nature of glycopeptide antibiotic class of CSP has made the understanding of the mechanism of chiral recognition at molecular level tricky. For instance, vancomycin molecule has 18 stereogenic centers in the molecule and offers a complex cyclodextrin-like chiral environment. In comparison to a single basket of cyclodextrins, vancomycin consists of three baskets, resulting in a more complex inclusion of appropriate guest molecules. The attractive forces include π-π interactions, hydrogen bonding, ionic interactions, and dipole stacking.
== History == Protease inhibitory activity in blood plasma was first reported in the late 1800s, but it was not until the 1950s that the serpins antithrombin and alpha 1-antitrypsin were isolated, with the subsequent recognition of their close family homology in 1979. That they belonged to a new protein family became apparent on their further alignment with the non-inhibitory egg-white protein ovalbumin, to give what was initially called the alpha1-antitrypsin-antithrombin III-ovalbumin superfamily of serine proteinase inhibitors, but was subsequently succinctly renamed as the Serpins. The initial characterisation of the new family centred on alpha1-antitrypsin, a serpin present in high concentration in blood plasma, the common genetic disorder of which was shown to cause a predisposition to the lung disease emphysema and to liver cirrhosis. The identification of the S and Z mutations responsible for the genetic deficiency and the subsequent sequence alignments of alpha1-antitrypsin and antithrombin in 1982 led to the recognition of the close homologies of the active sites of the two proteins, centred on a methionine in alpha1-antitrypsin as an inhibitor of tissue elastase and on arginine in antithrombin as an inhibitor of thrombin. The critical role of the active centre residue in determining the specificity of inhibition of serpins was unequivocally confirmed by the finding that a natural mutation of the active centre methionine in alpha1-antitrypsin to an arginine, as in antithrombin, resulted in a severe bleeding disorder.
== Apparatus == Instrumentation of supercritical fluid chromatography SFC has a similar setup to an HPLC instrument. The stationary phases are similar, and are packed inside similar column types. However, there are special features in these systems, because of the need to keep the mobile phase at supercritical fluidic state over the entire system. Temperature is critical to keep the fluids in a supercritical state, so there should be a heat control tool in the system, similar to that of GC. Also, there should be a precise pressure control mechanism, a restrictor to keep the pressure above a certain point, because pressure is another essential parameter to keep the mobile phase in a supercritical fluid state, so it is kept at the required minimal level. A microprocessor mechanism is placed in the instrument for SFC. This unit collects data for pressure, oven temperature, and detector performance to control the related pieces of the instrument. CO2 utilized in carbon dioxide dedicated pumps, which require that the incoming CO2 and pump heads be kept cold, in order to maintain the carbon dioxide at a temperature and pressure fit for supercritical fluidic state, where it can be effectively metered at a specified flow rate range. The CO2 subsequently becomes supercritical fluid throughout the injector and the column oven, when the temperature and pressure it is subjected to, are raised above the critical point of the liquid, thus the supercritical state is achieved.
Sources: en.wikipedia.org
== Wildlife == Flag Fen is also home to an abundance of wildlife owing to the variety of habitats on the site, which includes extensive grassland, traditionally managed hedgerows and woodland and a freshwater mere and dyke.
Another bill allowed developers to build housing on some lots previously zoned exclusively for commercial use without getting local governments' permission if a certain percentage of the housing was affordable. A third bill allowed for the construction of market-rate housing on some lots previously zoned exclusively for commercial use. At the signing ceremony for the latter two bills, Newsom warned local governments, which have a history of blocking and delaying housing developments, that they would be held accountable for future housing obstructionism. Other bills he signed required localities "to approve or deny various building permits within a strict timeline" and streamlined student and faculty housing projects by allowing California colleges to skip onerous review processes for new projects. Measures and actions to reduce homelessness in California have not yet solved the problem. The number of homeless reached a record 181,000 in January 2023. According to some, to cope with this problem, California must build more than 2.5 million housing units.
Galloway did not seek re-election in Bethnal Green and Bow at the 2010 general election, fulfilling a pledge he made to only serve one parliamentary term in the constituency. He instead opted to stand in the neighbouring constituency of Poplar and Limehouse and received 8,160 votes coming third after the Labour and Conservative candidates.
Adedapo Segun (North West) Bello Rabiu (North West) Yusuf Usman (North East) Babs Omotowa (North Central), former Managing Director of Nigeria Liquefied Natural Gas Austin Avuru (South-South), Non-Executive Director David Ige (South-West) Henry Obih (South-East) Lydia Jafiya, Permanent Secretary of the Federal Ministry of Finance (Ministry’s representative) Aminu Ahmed (Ministry of Petroleum Resources representative) The Group Chief Executive Officer, Bayo Ojulari, has since resumed his duties and represented NNPCL at various official events, including an empowerment program for National Youth Service Corps (NYSC) members.
==== Use of booby-trapped devices ==== Experts warned the 2024 Lebanon electronic device attacks potentially violated international humanitarian law. Josep Borrell, the European Union's High Representative for Foreign Affairs and Security Policy, questioned the legality of the pager attacks due to their high collateral damage among civilians, including the deaths of children. Jeanine Hennis-Plasschaert, the United Nations Special Coordinator for Lebanon, also raised concerns that the attacks were illegal. Belgian deputy prime minister Petra De Sutter went further, calling it a "terror attack". Volker Turk, the UN human rights chief, stated, "International humanitarian law prohibits the use of booby-trap devices in the form of apparently harmless portable objects". Booby traps are mostly outlawed under the Protocol on Mines, Booby-Traps and Other Devices ("Amended Protocol II") of the Convention on Certain Conventional Weapons, to which Israel is a party. Article 7, paragraph 2 of Amended Protocol II prohibits the use of "booby-traps or other devices in the form of apparently harmless portable objects which are specifically designed and constructed to contain explosive material." The rules of engagement of some countries, such as the United Kingdom, also ban explosive devices disguised as harmless items.
Sources: en.wikipedia.org
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.
The World Anti-Doping Agency classifies growth hormone fragments, including AOD-9604, as prohibited substances. The classification reflects concern about potential performance-enhancing use. Athletes are subject to testing for such peptides.
Detection typically uses liquid chromatography combined with mass spectrometry. These methods separate the peptide and identify it by mass. Immunoassays may screen samples but require confirmation by a more specific technique.
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.